332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster III

Role of therapeutic anticoagulation in kidney transplant recipients with thrombophilia A systematic review

Impact of venous thromboembolism on clinical outcomes in patients with brain cancer A national inpatient sample analysis from 2018 2020

Machine Learning–Based risk stratification in patients with direct anti‑xa Inhibitors–Related bleeding treated with four‑factor prothrombinex complex concentrate 4F PCC

Risk of venous thromboembolism associated with CDK 4 6 inhibitors and adjuvant hormonal therapy in non metastatic breast cancer A systematic review and meta analysis

Diagnostic accuracy of PET CT scan in differentiating malignant and bland thrombi in cancer patients A systematic review

Elucidating the chronological relationship between central venous line dysfunction infection and thrombosis in children with cancer A preliminary analysis

Reduced versus standard dose apixaban for secondary prevention of cancer associated venous thromboembolism A systematic review and meta analysis

Extended duration anticoagulation in cancer associated thrombosis

Elevated prevalence of hereditary thrombophilia variants in an endogamous jewish Mexican cohort

Risk factors for thrombo embolism in neonates A systematic review of the literature and call to action

Efficacy and safety of low dose vs standard dose direct oral anticoagulants for secondary prevention of venous thromboembolism A systematic review and meta analysis

Comparative effectiveness and safety of apixaban vs rivaroxaban in patients with cirrhosis and portal vein thrombosis An analysis of real world data

Pharmacometric analyses supporting apixaban doses in neonates with venous thromboembolism

Superficial vein thrombosis of the upper extremities A retrospective analysis of clot progression and role of thrombophilia testing

Is there an optimal time to transition to low dose direct oral anticoagulants